Bone Mineral Densitometry Bmd Market Key Players, Size, Share, Analysis and Forecast To 2031

New York, United States, 2022-May-24 — /EPR Network/ —

Bone Mineral Densitometry Bmd Market 2022

The global Bone Mineral Densitometry Bmd Market is expected to reach US$ 320 Mn by the year 2022 at a CAGR of 3.5%. Healthcare systems have been basically emphasizing on affordability as well as quality of the medical services. However, now, digitization has come through, which would drive revolution in the same healthcare vertical. The life sciences would go digitally innovative. This would be the way healthcare vertical would go in the next 10 years.

Rise in prevalence of osteoporosis in the aged population and women aged above 50 has led to a surge in demand for bone mineral densitometry. Rising awareness about osteoporosis and efforts by various foundations are increasing awareness among the women population is leading to increased demand for bone densitometers globally.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32513

Increasing number of spinal and hip fractures requiring bone mineral density scanning to avoid re-fractures is leading to higher installation of bone mineral densitometers in healthcare settings. Osteoporosis remains highly underdiagnosed and undertreated in South East Asia and many European countries.

There has been an increase in healthcare expenditure as well as reimbursements policies among developing nations, which is creating higher demand for bone densitometers. New product launches, acquisitions, and collaborations by key players are also expected to aid market expansion.

Company Profiles:

  • GE Healthcare
  • Hologic, Inc.
  • Beammed, Ltd.
  • Swissray International, Inc.
  • Osteosys Co. Ltd.
  • Diagnostic Medical System SA
  • Medonica Co., Ltd.
  • OsteometerMeditech
  • Hitachi Ltd.

bone-mineral-densitometry-bmd-market

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32513

Key Takeaways from Market Study

  • Axial bone densitometers hold over 68% value share, globally, as they are used for the detection of bone density in central sites, including the vertebral column, ribcage, and pelvic region.
  • Dual X-ray absorptiometry (DXA) is preferred due to higher number of bone density detections at central skeletal sites as compared to peripheral.
  • In terms of end user, hospitals contribute maximum share in the market due to higher footfall of patients as compared to other end-user facilities.
  • North America remains dominant in the global market for bone mineral densitometers, and will continue to hold strong revenue share of more than 51% over the forecast period.

BMD is witnessing growth in developed as well as emerging economies due to high prevalence of osteoporosis and osteoporotic fracture-related cases. Advancements in DXA technologies for higher precision and accuracy will lead a path toward improved diagnostic approaches to understand bone pathologies and preventing recurrent fractures,” says an analyst of Persistence Market Research.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32513

Acquisitions and Collaborations – Strategy by Key Players

Key manufacturers of bone mineral densitometers are collaborating with domestic vendors to expand their channel partnerships and increase their regional and global presence.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the bone mineral densitometry market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the product (axial bone densitometry and peripheral bone densitometry), technology (dual-energy X-ray absorptiometry (DXA), peripheral dual energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), and others), and end user (hospitals, orthopaedic clinics, and diagnostic centers), across seven key regions of the world (North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa).

Related Report-

Oncolytic Virus Immunotherapy Market

About us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Matched content

Editor’s pick

Express Press Release Distribution